[HTML][HTML] Coronavirus vaccine development: from SARS and MERS to COVID-19

YD Li, WY Chi, JH Su, L Ferrall, CF Hung… - Journal of biomedical …, 2020 - Springer
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new type of
coronavirus that causes the Coronavirus Disease 2019 (COVID-19), which has been the …

[HTML][HTML] Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2

I McDonald, SM Murray, CJ Reynolds, DM Altmann… - npj Vaccines, 2021 - nature.com
As SARS-CoV-2 vaccines are deployed worldwide, a comparative evaluation is important to
underpin decision-making. We here report a systematic literature review and meta-analysis …

[HTML][HTML] A perspective on potential antibody-dependent enhancement of SARS-CoV-2

AM Arvin, K Fink, MA Schmid, A Cathcart, R Spreafico… - Nature, 2020 - nature.com
Antibody-dependent enhancement (ADE) of disease is a general concern for the
development of vaccines and antibody therapies because the mechanisms that underlie …

[HTML][HTML] From SARS to MERS, thrusting coronaviruses into the spotlight

Z Song, Y Xu, L Bao, L Zhang, P Yu, Y Qu, H Zhu… - viruses, 2019 - mdpi.com
Coronaviruses (CoVs) have formerly been regarded as relatively harmless respiratory
pathogens to humans. However, two outbreaks of severe respiratory tract infection, caused …

[HTML][HTML] COVID-19: coronavirus vaccine development updates

J Zhao, S Zhao, J Ou, J Zhang, W Lan, W Guan… - Frontiers in …, 2020 - frontiersin.org
Coronavirus Disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), a newly emerged coronavirus, and has been pandemic since …

[HTML][HTML] Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection

L Liu, Q Wei, Q Lin, J Fang, H Wang, H Kwok, H Tang… - JCI insight, 2019 - ncbi.nlm.nih.gov
Newly emerging viruses, such as severe acute respiratory syndrome coronavirus (SARS-
CoV), Middle Eastern respiratory syndrome CoVs (MERS-CoV), and H7N9, cause fatal …

Inhibitors of SARS-CoV-2 entry: current and future opportunities

S Xiu, A Dick, H Ju, S Mirzaie, F Abdi… - Journal of medicinal …, 2020 - ACS Publications
Recently, a novel coronavirus initially designated 2019-nCoV but now termed SARS-CoV-2
has emerged and raised global concerns due to its virulence. SARS-CoV-2 is the etiological …

Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain

KG Nabel, SA Clark, S Shankar, J Pan, LE Clark… - Science, 2021 - science.org
Many studies have examined the impact of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) variants on neutralizing antibody activity after they have become dominant …

[HTML][HTML] Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections

H Lv, NC Wu, OTY Tsang, M Yuan, RAPM Perera… - Cell reports, 2020 - cell.com
Summary The World Health Organization has declared the ongoing outbreak of COVID-19,
which is caused by a novel coronavirus SARS-CoV-2, a pandemic. There is currently a lack …

[HTML][HTML] Vaccines for SARS-CoV-2: lessons from other coronavirus strains

E Padron-Regalado - Infectious diseases and therapy, 2020 - Springer
The emergence of the strain of coronavirus SARS-CoV-2 (severe acute respiratory
syndrome coronavirus 2) and its impact on global health have made imperative the …